ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Crude Unfractionated Heparin (UFH) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-30D7799
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global and Japan Crude Unfractionated Heparin UFH Market Insights Forecast to 2027
BUY CHAPTERS

Crude Unfractionated Heparin (UFH) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-30D7799
Report
October 2024
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
BIOIBERICA
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals

Crude Unfractionated Heparin (UFH) - Market Size

The global market for Crude Unfractionated Heparin (UFH) was estimated to be worth US$ 4474 million in 2023 and is forecast to a readjusted size of US$ 9643.9 million by 2030 with a CAGR of 10.9% during the forecast period 2024-2030

Crude Unfractionated Heparin (UFH) - Market

Crude Unfractionated Heparin (UFH) - Market

Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Currently, there are many players in this market. Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong, Hepac (Darling Ingredients), Huaian MDC Pharmaceutical, Yantai Dongcheng Biochemicals and some others are playing important roles in Crude Heparin industry. The market is dispersed for now and is seeing to be more concentrated in the future. Companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The total competition market for Crude Heparin will become more intense, while the market is going to be more concentrated in the future. Overall, the Crude Heparin products performance is positive with the current environment status.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Crude Unfractionated Heparin (UFH), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Crude Unfractionated Heparin (UFH) by region & country, by Type, and by Application.
The Crude Unfractionated Heparin (UFH) market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crude Unfractionated Heparin (UFH).
Market Segmentation

Scope of Crude Unfractionated Heparin (UFH) - Market Report

Report Metric Details
Report Name Crude Unfractionated Heparin (UFH) - Market
Forecasted market size in 2030 US$ 9643.9 million
CAGR 10.9%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Unfractionated Heparin (UFH)
  • Low-Molecular-Weight Heparin (LMWH)
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong, Hepac (Darling Ingredients), Huaian MDC Pharmaceutical, Yantai Dongcheng Biochemicals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Crude Unfractionated Heparin (UFH) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Crude Unfractionated Heparin (UFH) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Crude Unfractionated Heparin (UFH) in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Crude Unfractionated Heparin (UFH) - Market size in 2030?

Ans: The Crude Unfractionated Heparin (UFH) - Market size in 2030 will be US$ 9643.9 million.

Who are the main players in the Crude Unfractionated Heparin (UFH) - Market report?

Ans: The main players in the Crude Unfractionated Heparin (UFH) - Market are Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong, Hepac (Darling Ingredients), Huaian MDC Pharmaceutical, Yantai Dongcheng Biochemicals

What are the Application segmentation covered in the Crude Unfractionated Heparin (UFH) - Market report?

Ans: The Applications covered in the Crude Unfractionated Heparin (UFH) - Market report are Unfractionated Heparin (UFH), Low-Molecular-Weight Heparin (LMWH)

What are the Type segmentation covered in the Crude Unfractionated Heparin (UFH) - Market report?

Ans: The Types covered in the Crude Unfractionated Heparin (UFH) - Market report are Pig Intestine Mucosa Heparin, Bovine Heparin and Others

Recommended Reports

Heparin Product Markets

Anticoagulant Drugs

Heparin Accessories & Devices

1 Market Overview
1.1 Crude Unfractionated Heparin (UFH) Product Introduction
1.2 Global Crude Unfractionated Heparin (UFH) Market Size Forecast
1.2.1 Global Crude Unfractionated Heparin (UFH) Sales Value (2019-2030)
1.2.2 Global Crude Unfractionated Heparin (UFH) Sales Volume (2019-2030)
1.2.3 Global Crude Unfractionated Heparin (UFH) Sales Price (2019-2030)
1.3 Crude Unfractionated Heparin (UFH) Market Trends & Drivers
1.3.1 Crude Unfractionated Heparin (UFH) Industry Trends
1.3.2 Crude Unfractionated Heparin (UFH) Market Drivers & Opportunity
1.3.3 Crude Unfractionated Heparin (UFH) Market Challenges
1.3.4 Crude Unfractionated Heparin (UFH) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Crude Unfractionated Heparin (UFH) Players Revenue Ranking (2023)
2.2 Global Crude Unfractionated Heparin (UFH) Revenue by Company (2019-2024)
2.3 Global Crude Unfractionated Heparin (UFH) Players Sales Volume Ranking (2023)
2.4 Global Crude Unfractionated Heparin (UFH) Sales Volume by Company Players (2019-2024)
2.5 Global Crude Unfractionated Heparin (UFH) Average Price by Company (2019-2024)
2.6 Key Manufacturers Crude Unfractionated Heparin (UFH) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Crude Unfractionated Heparin (UFH) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Crude Unfractionated Heparin (UFH)
2.9 Crude Unfractionated Heparin (UFH) Market Competitive Analysis
2.9.1 Crude Unfractionated Heparin (UFH) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Crude Unfractionated Heparin (UFH) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crude Unfractionated Heparin (UFH) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Pig Intestine Mucosa Heparin
3.1.2 Bovine Heparin and Others
3.2 Global Crude Unfractionated Heparin (UFH) Sales Value by Type
3.2.1 Global Crude Unfractionated Heparin (UFH) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Crude Unfractionated Heparin (UFH) Sales Value, by Type (2019-2030)
3.2.3 Global Crude Unfractionated Heparin (UFH) Sales Value, by Type (%) (2019-2030)
3.3 Global Crude Unfractionated Heparin (UFH) Sales Volume by Type
3.3.1 Global Crude Unfractionated Heparin (UFH) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Crude Unfractionated Heparin (UFH) Sales Volume, by Type (2019-2030)
3.3.3 Global Crude Unfractionated Heparin (UFH) Sales Volume, by Type (%) (2019-2030)
3.4 Global Crude Unfractionated Heparin (UFH) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Unfractionated Heparin (UFH)
4.1.2 Low-Molecular-Weight Heparin (LMWH)
4.2 Global Crude Unfractionated Heparin (UFH) Sales Value by Application
4.2.1 Global Crude Unfractionated Heparin (UFH) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Crude Unfractionated Heparin (UFH) Sales Value, by Application (2019-2030)
4.2.3 Global Crude Unfractionated Heparin (UFH) Sales Value, by Application (%) (2019-2030)
4.3 Global Crude Unfractionated Heparin (UFH) Sales Volume by Application
4.3.1 Global Crude Unfractionated Heparin (UFH) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Crude Unfractionated Heparin (UFH) Sales Volume, by Application (2019-2030)
4.3.3 Global Crude Unfractionated Heparin (UFH) Sales Volume, by Application (%) (2019-2030)
4.4 Global Crude Unfractionated Heparin (UFH) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Crude Unfractionated Heparin (UFH) Sales Value by Region
5.1.1 Global Crude Unfractionated Heparin (UFH) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Crude Unfractionated Heparin (UFH) Sales Value by Region (2019-2024)
5.1.3 Global Crude Unfractionated Heparin (UFH) Sales Value by Region (2025-2030)
5.1.4 Global Crude Unfractionated Heparin (UFH) Sales Value by Region (%), (2019-2030)
5.2 Global Crude Unfractionated Heparin (UFH) Sales Volume by Region
5.2.1 Global Crude Unfractionated Heparin (UFH) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Crude Unfractionated Heparin (UFH) Sales Volume by Region (2019-2024)
5.2.3 Global Crude Unfractionated Heparin (UFH) Sales Volume by Region (2025-2030)
5.2.4 Global Crude Unfractionated Heparin (UFH) Sales Volume by Region (%), (2019-2030)
5.3 Global Crude Unfractionated Heparin (UFH) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Crude Unfractionated Heparin (UFH) Sales Value, 2019-2030
5.4.2 North America Crude Unfractionated Heparin (UFH) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Crude Unfractionated Heparin (UFH) Sales Value, 2019-2030
5.5.2 Europe Crude Unfractionated Heparin (UFH) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Crude Unfractionated Heparin (UFH) Sales Value, 2019-2030
5.6.2 Asia Pacific Crude Unfractionated Heparin (UFH) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Crude Unfractionated Heparin (UFH) Sales Value, 2019-2030
5.7.2 South America Crude Unfractionated Heparin (UFH) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Crude Unfractionated Heparin (UFH) Sales Value, 2019-2030
5.8.2 Middle East & Africa Crude Unfractionated Heparin (UFH) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Crude Unfractionated Heparin (UFH) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Crude Unfractionated Heparin (UFH) Sales Value
6.2.1 Key Countries/Regions Crude Unfractionated Heparin (UFH) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Crude Unfractionated Heparin (UFH) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Crude Unfractionated Heparin (UFH) Sales Value, 2019-2030
6.3.2 United States Crude Unfractionated Heparin (UFH) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Crude Unfractionated Heparin (UFH) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Crude Unfractionated Heparin (UFH) Sales Value, 2019-2030
6.4.2 Europe Crude Unfractionated Heparin (UFH) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Crude Unfractionated Heparin (UFH) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Crude Unfractionated Heparin (UFH) Sales Value, 2019-2030
6.5.2 China Crude Unfractionated Heparin (UFH) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Crude Unfractionated Heparin (UFH) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Crude Unfractionated Heparin (UFH) Sales Value, 2019-2030
6.6.2 Japan Crude Unfractionated Heparin (UFH) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Crude Unfractionated Heparin (UFH) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Crude Unfractionated Heparin (UFH) Sales Value, 2019-2030
6.7.2 South Korea Crude Unfractionated Heparin (UFH) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Crude Unfractionated Heparin (UFH) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Crude Unfractionated Heparin (UFH) Sales Value, 2019-2030
6.8.2 Southeast Asia Crude Unfractionated Heparin (UFH) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Crude Unfractionated Heparin (UFH) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Crude Unfractionated Heparin (UFH) Sales Value, 2019-2030
6.9.2 India Crude Unfractionated Heparin (UFH) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Crude Unfractionated Heparin (UFH) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bioiberica
7.1.1 Bioiberica Company Information
7.1.2 Bioiberica Introduction and Business Overview
7.1.3 Bioiberica Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Bioiberica Crude Unfractionated Heparin (UFH) Product Offerings
7.1.5 Bioiberica Recent Development
7.2 Shenzhen Hepalink
7.2.1 Shenzhen Hepalink Company Information
7.2.2 Shenzhen Hepalink Introduction and Business Overview
7.2.3 Shenzhen Hepalink Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Shenzhen Hepalink Crude Unfractionated Heparin (UFH) Product Offerings
7.2.5 Shenzhen Hepalink Recent Development
7.3 Sanofi
7.3.1 Sanofi Company Information
7.3.2 Sanofi Introduction and Business Overview
7.3.3 Sanofi Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Sanofi Crude Unfractionated Heparin (UFH) Product Offerings
7.3.5 Sanofi Recent Development
7.4 Nanjing King-friend
7.4.1 Nanjing King-friend Company Information
7.4.2 Nanjing King-friend Introduction and Business Overview
7.4.3 Nanjing King-friend Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Nanjing King-friend Crude Unfractionated Heparin (UFH) Product Offerings
7.4.5 Nanjing King-friend Recent Development
7.5 Fengrun Biological Technology
7.5.1 Fengrun Biological Technology Company Information
7.5.2 Fengrun Biological Technology Introduction and Business Overview
7.5.3 Fengrun Biological Technology Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Fengrun Biological Technology Crude Unfractionated Heparin (UFH) Product Offerings
7.5.5 Fengrun Biological Technology Recent Development
7.6 Aspen Oss
7.6.1 Aspen Oss Company Information
7.6.2 Aspen Oss Introduction and Business Overview
7.6.3 Aspen Oss Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Aspen Oss Crude Unfractionated Heparin (UFH) Product Offerings
7.6.5 Aspen Oss Recent Development
7.7 Hebei Changshan Biochemical
7.7.1 Hebei Changshan Biochemical Company Information
7.7.2 Hebei Changshan Biochemical Introduction and Business Overview
7.7.3 Hebei Changshan Biochemical Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Hebei Changshan Biochemical Crude Unfractionated Heparin (UFH) Product Offerings
7.7.5 Hebei Changshan Biochemical Recent Development
7.8 Changzhou Qianhong
7.8.1 Changzhou Qianhong Company Information
7.8.2 Changzhou Qianhong Introduction and Business Overview
7.8.3 Changzhou Qianhong Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Changzhou Qianhong Crude Unfractionated Heparin (UFH) Product Offerings
7.8.5 Changzhou Qianhong Recent Development
7.9 Hepac (Darling Ingredients)
7.9.1 Hepac (Darling Ingredients) Company Information
7.9.2 Hepac (Darling Ingredients) Introduction and Business Overview
7.9.3 Hepac (Darling Ingredients) Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Hepac (Darling Ingredients) Crude Unfractionated Heparin (UFH) Product Offerings
7.9.5 Hepac (Darling Ingredients) Recent Development
7.10 Huaian MDC Pharmaceutical
7.10.1 Huaian MDC Pharmaceutical Company Information
7.10.2 Huaian MDC Pharmaceutical Introduction and Business Overview
7.10.3 Huaian MDC Pharmaceutical Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Huaian MDC Pharmaceutical Crude Unfractionated Heparin (UFH) Product Offerings
7.10.5 Huaian MDC Pharmaceutical Recent Development
7.11 Yantai Dongcheng Biochemicals
7.11.1 Yantai Dongcheng Biochemicals Company Information
7.11.2 Yantai Dongcheng Biochemicals Introduction and Business Overview
7.11.3 Yantai Dongcheng Biochemicals Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Yantai Dongcheng Biochemicals Crude Unfractionated Heparin (UFH) Product Offerings
7.11.5 Yantai Dongcheng Biochemicals Recent Development
8 Industry Chain Analysis
8.1 Crude Unfractionated Heparin (UFH) Industrial Chain
8.2 Crude Unfractionated Heparin (UFH) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Crude Unfractionated Heparin (UFH) Sales Model
8.5.2 Sales Channel
8.5.3 Crude Unfractionated Heparin (UFH) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
BIOIBERICA
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals
List of Tables
    Table 1. Crude Unfractionated Heparin (UFH) Market Trends
    Table 2. Crude Unfractionated Heparin (UFH) Market Drivers & Opportunity
    Table 3. Crude Unfractionated Heparin (UFH) Market Challenges
    Table 4. Crude Unfractionated Heparin (UFH) Market Restraints
    Table 5. Global Crude Unfractionated Heparin (UFH) Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Crude Unfractionated Heparin (UFH) Revenue Market Share by Company (2019-2024)
    Table 7. Global Crude Unfractionated Heparin (UFH) Sales Volume by Company (2019-2024) & (MT)
    Table 8. Global Crude Unfractionated Heparin (UFH) Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Crude Unfractionated Heparin (UFH) Price by Company (2019-2024) & (US$/Kg)
    Table 10. Key Manufacturers Crude Unfractionated Heparin (UFH) Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Crude Unfractionated Heparin (UFH) Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Crude Unfractionated Heparin (UFH)
    Table 13. Global Crude Unfractionated Heparin (UFH) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crude Unfractionated Heparin (UFH) as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Crude Unfractionated Heparin (UFH) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Crude Unfractionated Heparin (UFH) Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Crude Unfractionated Heparin (UFH) Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Crude Unfractionated Heparin (UFH) Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Crude Unfractionated Heparin (UFH) Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Crude Unfractionated Heparin (UFH) Sales Volume by Type: 2019 VS 2023 VS 2030 (MT)
    Table 22. Global Crude Unfractionated Heparin (UFH) Sales Volume by Type (2019-2024) & (MT)
    Table 23. Global Crude Unfractionated Heparin (UFH) Sales Volume by Type (2025-2030) & (MT)
    Table 24. Global Crude Unfractionated Heparin (UFH) Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Crude Unfractionated Heparin (UFH) Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Crude Unfractionated Heparin (UFH) Price by Type (2019-2024) & (US$/Kg)
    Table 27. Global Crude Unfractionated Heparin (UFH) Price by Type (2025-2030) & (US$/Kg)
    Table 28. Global Crude Unfractionated Heparin (UFH) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Crude Unfractionated Heparin (UFH) Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Crude Unfractionated Heparin (UFH) Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Crude Unfractionated Heparin (UFH) Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Crude Unfractionated Heparin (UFH) Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Crude Unfractionated Heparin (UFH) Sales Volume by Application: 2019 VS 2023 VS 2030 (MT)
    Table 34. Global Crude Unfractionated Heparin (UFH) Sales Volume by Application (2019-2024) & (MT)
    Table 35. Global Crude Unfractionated Heparin (UFH) Sales Volume by Application (2025-2030) & (MT)
    Table 36. Global Crude Unfractionated Heparin (UFH) Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Crude Unfractionated Heparin (UFH) Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Crude Unfractionated Heparin (UFH) Price by Application (2019-2024) & (US$/Kg)
    Table 39. Global Crude Unfractionated Heparin (UFH) Price by Application (2025-2030) & (US$/Kg)
    Table 40. Global Crude Unfractionated Heparin (UFH) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Crude Unfractionated Heparin (UFH) Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Crude Unfractionated Heparin (UFH) Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Crude Unfractionated Heparin (UFH) Sales Value by Region (2019-2024) & (%)
    Table 44. Global Crude Unfractionated Heparin (UFH) Sales Value by Region (2025-2030) & (%)
    Table 45. Global Crude Unfractionated Heparin (UFH) Sales Volume by Region (MT): 2019 VS 2023 VS 2030
    Table 46. Global Crude Unfractionated Heparin (UFH) Sales Volume by Region (2019-2024) & (MT)
    Table 47. Global Crude Unfractionated Heparin (UFH) Sales Volume by Region (2025-2030) & (MT)
    Table 48. Global Crude Unfractionated Heparin (UFH) Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Crude Unfractionated Heparin (UFH) Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Crude Unfractionated Heparin (UFH) Average Price by Region (2019-2024) & (US$/Kg)
    Table 51. Global Crude Unfractionated Heparin (UFH) Average Price by Region (2025-2030) & (US$/Kg)
    Table 52. Key Countries/Regions Crude Unfractionated Heparin (UFH) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Crude Unfractionated Heparin (UFH) Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Crude Unfractionated Heparin (UFH) Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Crude Unfractionated Heparin (UFH) Sales Volume, (2019-2024) & (MT)
    Table 56. Key Countries/Regions Crude Unfractionated Heparin (UFH) Sales Volume, (2025-2030) & (MT)
    Table 57. Bioiberica Company Information
    Table 58. Bioiberica Introduction and Business Overview
    Table 59. Bioiberica Crude Unfractionated Heparin (UFH) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 60. Bioiberica Crude Unfractionated Heparin (UFH) Product Offerings
    Table 61. Bioiberica Recent Development
    Table 62. Shenzhen Hepalink Company Information
    Table 63. Shenzhen Hepalink Introduction and Business Overview
    Table 64. Shenzhen Hepalink Crude Unfractionated Heparin (UFH) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 65. Shenzhen Hepalink Crude Unfractionated Heparin (UFH) Product Offerings
    Table 66. Shenzhen Hepalink Recent Development
    Table 67. Sanofi Company Information
    Table 68. Sanofi Introduction and Business Overview
    Table 69. Sanofi Crude Unfractionated Heparin (UFH) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 70. Sanofi Crude Unfractionated Heparin (UFH) Product Offerings
    Table 71. Sanofi Recent Development
    Table 72. Nanjing King-friend Company Information
    Table 73. Nanjing King-friend Introduction and Business Overview
    Table 74. Nanjing King-friend Crude Unfractionated Heparin (UFH) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 75. Nanjing King-friend Crude Unfractionated Heparin (UFH) Product Offerings
    Table 76. Nanjing King-friend Recent Development
    Table 77. Fengrun Biological Technology Company Information
    Table 78. Fengrun Biological Technology Introduction and Business Overview
    Table 79. Fengrun Biological Technology Crude Unfractionated Heparin (UFH) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 80. Fengrun Biological Technology Crude Unfractionated Heparin (UFH) Product Offerings
    Table 81. Fengrun Biological Technology Recent Development
    Table 82. Aspen Oss Company Information
    Table 83. Aspen Oss Introduction and Business Overview
    Table 84. Aspen Oss Crude Unfractionated Heparin (UFH) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 85. Aspen Oss Crude Unfractionated Heparin (UFH) Product Offerings
    Table 86. Aspen Oss Recent Development
    Table 87. Hebei Changshan Biochemical Company Information
    Table 88. Hebei Changshan Biochemical Introduction and Business Overview
    Table 89. Hebei Changshan Biochemical Crude Unfractionated Heparin (UFH) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 90. Hebei Changshan Biochemical Crude Unfractionated Heparin (UFH) Product Offerings
    Table 91. Hebei Changshan Biochemical Recent Development
    Table 92. Changzhou Qianhong Company Information
    Table 93. Changzhou Qianhong Introduction and Business Overview
    Table 94. Changzhou Qianhong Crude Unfractionated Heparin (UFH) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 95. Changzhou Qianhong Crude Unfractionated Heparin (UFH) Product Offerings
    Table 96. Changzhou Qianhong Recent Development
    Table 97. Hepac (Darling Ingredients) Company Information
    Table 98. Hepac (Darling Ingredients) Introduction and Business Overview
    Table 99. Hepac (Darling Ingredients) Crude Unfractionated Heparin (UFH) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 100. Hepac (Darling Ingredients) Crude Unfractionated Heparin (UFH) Product Offerings
    Table 101. Hepac (Darling Ingredients) Recent Development
    Table 102. Huaian MDC Pharmaceutical Company Information
    Table 103. Huaian MDC Pharmaceutical Introduction and Business Overview
    Table 104. Huaian MDC Pharmaceutical Crude Unfractionated Heparin (UFH) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 105. Huaian MDC Pharmaceutical Crude Unfractionated Heparin (UFH) Product Offerings
    Table 106. Huaian MDC Pharmaceutical Recent Development
    Table 107. Yantai Dongcheng Biochemicals Company Information
    Table 108. Yantai Dongcheng Biochemicals Introduction and Business Overview
    Table 109. Yantai Dongcheng Biochemicals Crude Unfractionated Heparin (UFH) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 110. Yantai Dongcheng Biochemicals Crude Unfractionated Heparin (UFH) Product Offerings
    Table 111. Yantai Dongcheng Biochemicals Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Crude Unfractionated Heparin (UFH) Downstream Customers
    Table 115. Crude Unfractionated Heparin (UFH) Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Crude Unfractionated Heparin (UFH) Product Picture
    Figure 2. Global Crude Unfractionated Heparin (UFH) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Crude Unfractionated Heparin (UFH) Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Crude Unfractionated Heparin (UFH) Sales Volume (2019-2030) & (MT)
    Figure 5. Global Crude Unfractionated Heparin (UFH) Sales Price (2019-2030) & (US$/Kg)
    Figure 6. Crude Unfractionated Heparin (UFH) Report Years Considered
    Figure 7. Global Crude Unfractionated Heparin (UFH) Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Crude Unfractionated Heparin (UFH) Players Sales Volume Ranking (2023) & (MT)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Crude Unfractionated Heparin (UFH) Revenue in 2023
    Figure 10. Crude Unfractionated Heparin (UFH) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Pig Intestine Mucosa Heparin Picture
    Figure 12. Bovine Heparin and Others Picture
    Figure 13. Global Crude Unfractionated Heparin (UFH) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Crude Unfractionated Heparin (UFH) Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Crude Unfractionated Heparin (UFH) Sales Volume by Type (2019 VS 2023 VS 2030) & (MT)
    Figure 16. Global Crude Unfractionated Heparin (UFH) Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Crude Unfractionated Heparin (UFH) Price by Type (2019-2030) & (US$/Kg)
    Figure 18. Product Picture of Unfractionated Heparin (UFH)
    Figure 19. Product Picture of Low-Molecular-Weight Heparin (LMWH)
    Figure 20. Global Crude Unfractionated Heparin (UFH) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Crude Unfractionated Heparin (UFH) Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Crude Unfractionated Heparin (UFH) Sales Volume by Application (2019 VS 2023 VS 2030) & (MT)
    Figure 23. Global Crude Unfractionated Heparin (UFH) Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Crude Unfractionated Heparin (UFH) Price by Application (2019-2030) & (US$/Kg)
    Figure 25. North America Crude Unfractionated Heparin (UFH) Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Crude Unfractionated Heparin (UFH) Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Crude Unfractionated Heparin (UFH) Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Crude Unfractionated Heparin (UFH) Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Crude Unfractionated Heparin (UFH) Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Crude Unfractionated Heparin (UFH) Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Crude Unfractionated Heparin (UFH) Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Crude Unfractionated Heparin (UFH) Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Crude Unfractionated Heparin (UFH) Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Crude Unfractionated Heparin (UFH) Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Crude Unfractionated Heparin (UFH) Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Crude Unfractionated Heparin (UFH) Sales Volume (%), (2019-2030)
    Figure 37. United States Crude Unfractionated Heparin (UFH) Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Crude Unfractionated Heparin (UFH) Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Crude Unfractionated Heparin (UFH) Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Crude Unfractionated Heparin (UFH) Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Crude Unfractionated Heparin (UFH) Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Crude Unfractionated Heparin (UFH) Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Crude Unfractionated Heparin (UFH) Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Crude Unfractionated Heparin (UFH) Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Crude Unfractionated Heparin (UFH) Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Crude Unfractionated Heparin (UFH) Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Crude Unfractionated Heparin (UFH) Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Crude Unfractionated Heparin (UFH) Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Crude Unfractionated Heparin (UFH) Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Crude Unfractionated Heparin (UFH) Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Crude Unfractionated Heparin (UFH) Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Crude Unfractionated Heparin (UFH) Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Crude Unfractionated Heparin (UFH) Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Crude Unfractionated Heparin (UFH) Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Crude Unfractionated Heparin (UFH) Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Crude Unfractionated Heparin (UFH) Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Crude Unfractionated Heparin (UFH) Sales Value by Application (%), 2023 VS 2030
    Figure 58. Crude Unfractionated Heparin (UFH) Industrial Chain
    Figure 59. Crude Unfractionated Heparin (UFH) Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Crude Heparin Market Research Report 2024
Unfractionated Heparin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Heparin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Low Molecular Weight Heparin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Heparin Sodium Active Pharmaceutical Ingredient Market Research Report 2024
Global Low Molecular Weight Heparin Market Research Report 2025
Global Porcine Heparin APIs Market Research Report 2024
Bovine Heparin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lab synthesized Heparin Market Research Report 2024
Heparin Heparin Sodium and Heparin Calcium Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Crude Porcine Heparin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
High Purity Heparin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Heparin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Heparin Market Insights Forecast to 2030
High Purity Heparin Sodium Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Heparin Sodium API and Heparin Calcium API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Heparin Sodium API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Low Molecular Weight Heparin LMWHs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Low Molecular Weight Heparin Sodium Market Insights Forecast to 2030
Heparin Low Molecular Weight Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions